Compare Cassava Sciences Inc (FLNA) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Pinterest Inc — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Pinterest Inc trades at $23.5 (market cap $13.26B). The key difference: Pinterest Inc is far larger — about 249.5× Cassava Sciences Inc's market cap, and Pinterest Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | PINS | |
|---|---|---|
Market Cap | $53.14M | $13.26B |
Sector | Health | Media |
52-Week High | $4.64 | $39.17 |
52-Week Low | $1.09 | $15.42 |
Enterprise Value | -$33.43M | $13.17B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
Pinterest (PINS) trades at $23.52, up 4.05% in the last session, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 EPS of $0.27, beating expectations, and maintains strong revenue growth, reaching $4.22B in 2025. Recent news highlights AI-driven shopping initiatives and user growth, with 631 million monthly active users in Q1 2026 (Zacks Investment Research, 2026-06-23).
The stock offers upside to the consensus price target of $27.53, with 54% of analysts rating it a buy. However, high valuation multiples (P/E of 49.33) and competitive pressures pose risks. Net cash flow turned negative in 2025, though operating cash flow remains robust at $1.28B, indicating underlying business strength amid investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
